EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-1β contributes to neurological disability in NMOSD AQP4 + Patients

Antonio Bruno, Angela Borrelli, Gianluca Lauritano, Sonia Di Lemme, Veronica Di Caprio, Roberta Fantozzi, Ettore Dolcetti, Federica Azzolini, Luana Gilio, Giovanni Galifi, Roberto Furlan, Annamaria Finardi und 6 weitere

Neurological Sciences · 2025-12 · 46 (12) · 6687-6695

DOI: 10.1007/s10072-025-08526-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, online erschienen am 08.10.2025. Verfasst von Antonio Bruno und 17 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Neuromed, Via Atinense, 18, Pozzilli (IS), 86077, Italy. Hauptthemen laut MEDLINE: Neuromyelitis Optica, Aquaporin 4, Interleukin-1beta, Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Fondazione Italiana Sclerosi Multipla.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neuromyelitis Optica Spectrum Disorder (NMOSD) is a central nervous system inflammatory disease that causes severe disability. Differently from relapsing-remitting multiple sclerosis (RRMS) a group of patients present aquaporin-4 (AQP4) antibodies in the serum. Although its pathogenesis is unclear, cytokine profiles may impact disease activity and severity.

Objective

To analyze cerebrospinal fluid (CSF) cytokine levels in NMOSD AQP4 + and their relationship with neurological disability, comparing findings with RRMS patients and non-inflammatory controls (NIC).

Methods

Sixty-four participants were recruited: 11 NMOSD AQP4+, 29 RRMS, and 24 NIC. CSF cytokine levels were measured using a multiplex assay. Group comparisons were performed with Kruskal-Wallis and Mann-Whitney U tests, while linear regression models evaluated the association between cytokine levels and Expanded Disability Status Scale (EDSS) scores.

Results

NMOSD AQP4 + patients displayed significantly higher CSF levels of IL-1β ( p = 0.040), TNF-α ( p < 0.001), G-CSF ( p = 0.003), Eotaxin ( p = 0.008), and MIP-1α ( p = 0.005) compared to RRMS and NIC. Moreover, IL-1β CSF levels were positively associated with disability at the time of lumbar puncture (β = 22.24, SE = 7.73, p = 0.018), a relationship that remained significant after adjusting for age (β = 18.96, SE = 6.33, p = 0.040).

Conclusions

Expression of proinflammatory cytokines may differ between NMOSD and RRMS. Elevated IL-1β levels in NMOSD AQP4 + patients are associated with neurological disability, suggesting a potential role as a biomarker of disease severity. Further studies are needed to confirm these findings and evaluate the therapeutic potential of targeting IL-1β in NMOSD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuromyelitis OpticaAquaporin 4Interleukin-1betaMultiple Sclerosis, Relapsing-RemittingHumansFemaleMaleAdultMiddle AgedCytokinesDisability EvaluationYoung AdultSeverity of Illness IndexBiomarkers

Stichwörter der Autor:innen

Aquaporin-4CytokinesDisabilityIL-1βNMOSDNeuroinflammation

Substanzen

Aquaporin 4Interleukin-1betaAQP4 protein, humanIL1B protein, humanCytokinesBiomarkers

Autor:innen und Institutionen

  • IRCCS Neuromed, Via Atinense, 18, Pozzilli (IS), 86077, Italy.
  • Faculty of Psychology, International Telematic University Uninettuno, Rome, Italy.
  • Clinical Neuroimmunology Unit, Institute of Experimental Neurology (INSpe), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
  • Synaptic Immunopathology Lab, IRCCS San Raffaele Roma, Roma, Italy.
  • Department of Human Sciences and Quality of Life Promotion, University of Rome San Raffaele, Rome, Italy.
  • IRCCS Neuromed, Via Atinense, 18, Pozzilli (IS), 86077, Italy. centonze@uniroma2.it.

Förderung

  • Ministero della Salute
  • Fondazione Italiana Sclerosi Multipla

Zitieren

APA

Bruno, A., Borrelli, A., Lauritano, G., Di Lemme, S., Di Caprio, V., Fantozzi, R., Dolcetti, E., Azzolini, F., Gilio, L., Galifi, G., Furlan, R., Finardi, A., De Vito, F., Musella, A., Mandolesi, G., Bassi, M. S., Centonze, D., & Buttari, F. (2025). IL-1β contributes to neurological disability in NMOSD AQP4 + Patients. Neurological Sciences, 46(12), 6687-6695. https://doi.org/10.1007/s10072-025-08526-8

Vancouver

Bruno A, Borrelli A, Lauritano G, Di Lemme S, Di Caprio V, Fantozzi R, et al. IL-1β contributes to neurological disability in NMOSD AQP4 + Patients. Neurological Sciences. 2025;46(12):6687-6695. doi:10.1007/s10072-025-08526-8

BibTeX
@article{Bruno2025,
  author = {Bruno, Antonio and Borrelli, Angela and Lauritano, Gianluca and Di Lemme, Sonia and Di Caprio, Veronica and Fantozzi, Roberta and Dolcetti, Ettore and Azzolini, Federica and Gilio, Luana and Galifi, Giovanni and Furlan, Roberto and Finardi, Annamaria and De Vito, Francesca and Musella, Alessandra and Mandolesi, Georgia and Bassi, Mario Stampanoni and Centonze, Diego and Buttari, Fabio},
  title = {IL-1β contributes to neurological disability in NMOSD AQP4 + Patients},
  journal = {Neurological Sciences},
  year = {2025},
  volume = {46},
  number = {12},
  pages = {6687--6695},
  doi = {10.1007/s10072-025-08526-8}
}
Kostenlos starten →